Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders.
Du
Jing
J
Laboratory of Molecular Pathophysiology, National Institute of Mental Health, Bethesda, MD 20892, USA.
Szabo
Steven T
ST
Gray
Neil A
NA
Manji
Husseini K
HK
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001007:Anxiety / Q000235:genetics* / Q000503:physiopathology; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000235:genetics / Q000502:physiology*; D018698:Glutamic Acid / Q000502:physiology; D006801:Humans; D019964:Mood Disorders / Q000235:genetics* / Q000503:physiopathology; D009473:Neuronal Plasticity / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology
D000928:Antidepressive Agents; D018698:Glutamic Acid; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases